The biocorona: a challenge for the biomedical application of nanoparticles
暂无分享,去创建一个
[1] K. Landfester,et al. Complementary analysis of the hard and soft protein corona: sample preparation critically effects corona composition. , 2015, Nanoscale.
[2] Krishnendu Roy,et al. Intracellular delivery of polymeric nanocarriers: a matter of size, shape, charge, elasticity and surface composition. , 2013, Therapeutic delivery.
[3] Effects of surface functional groups on the formation of nanoparticle-protein corona. , 2012, Applied physics letters.
[4] A. Rao,et al. Influence of carbon nanomaterial defects on the formation of protein corona. , 2015, RSC advances.
[5] A. Neves,et al. Brain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein E , 2016, Journal of Nanobiotechnology.
[6] Morteza Mahmoudi,et al. Biological Identity of Nanoparticles In Vivo: Clinical Implications of the Protein Corona. , 2017, Trends in biotechnology.
[7] Christoffer Åberg,et al. Mapping protein binding sites on the biomolecular corona of nanoparticles. , 2015, Nature nanotechnology.
[8] W. Bai,et al. Implications of scavenger receptors in the safe development of nanotherapeutics. , 2015, Receptors & clinical investigation.
[9] Giulio Caracciolo,et al. Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells. , 2014, Nanoscale.
[10] A. Allen,et al. Dissolution, agglomerate morphology, and stability limits of protein-coated silver nanoparticles. , 2014, Langmuir : the ACS journal of surfaces and colloids.
[11] Achyut J. Raghavendra,et al. From the Cover: Disease-Induced Disparities in Formation of the Nanoparticle-Biocorona and the Toxicological Consequences. , 2016, Toxicological sciences : an official journal of the Society of Toxicology.
[12] Andrew Emili,et al. Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. , 2014, ACS nano.
[13] Ramakrishna Podila,et al. Formation of a protein corona on silver nanoparticles mediates cellular toxicity via scavenger receptors. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.
[14] R. Podila,et al. A hyperspectral and toxicological analysis of protein corona impact on silver nanoparticle properties, intracellular modifications, and macrophage activation , 2015, International journal of nanomedicine.
[15] Paolo Bergese,et al. Surfactant titration of nanoparticle-protein corona. , 2014, Analytical chemistry.
[16] Jim E Riviere,et al. A computational framework for interspecies pharmacokinetics, exposure and toxicity assessment of gold nanoparticles. , 2016, Nanomedicine.
[17] Andrzej S Pitek,et al. Characterization of the bionano interface and mapping extrinsic interactions of the corona of nanomaterials. , 2015, Nanoscale.
[18] Yoram Cohen,et al. Evaluation of Toxicity Ranking for Metal Oxide Nanoparticles via an in Vitro Dosimetry Model. , 2015, ACS nano.
[19] Bengt-Harald Jonsson,et al. Protein adsorption onto silica nanoparticles: conformational changes depend on the particles' curvature and the protein stability. , 2004, Langmuir : the ACS journal of surfaces and colloids.
[20] A. Salvati,et al. Balancing the effect of corona on therapeutic efficacy and macrophage uptake of lipid nanocapsules. , 2015, Biomaterials.
[21] C. Scoglio,et al. Predicting the impact of biocorona formation kinetics on interspecies extrapolations of nanoparticle biodistribution modeling. , 2015, Nanomedicine.
[22] Hari Sowrirajan,et al. Impact of Silver and Iron Nanoparticle Exposure on Cholesterol Uptake by Macrophages , 2017, Journal of nanomaterials.
[23] Warren C. W. Chan,et al. Polyethylene glycol backfilling mitigates the negative impact of the protein corona on nanoparticle cell targeting. , 2014, Angewandte Chemie.
[24] Sara Linse,et al. Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.
[25] Marco P Monopoli,et al. Biomolecular coronas provide the biological identity of nanosized materials. , 2012, Nature nanotechnology.
[26] K. Dawson,et al. Magnetic nanoparticles to recover cellular organelles and study the time resolved nanoparticle-cell interactome throughout uptake. , 2014, Small.
[27] Joel G Pounds,et al. ISDD: A computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies , 2010, Particle and Fibre Toxicology.
[28] K. Fent,et al. Silver nanoparticles induce endoplasmatic reticulum stress response in zebrafish. , 2013, Toxicology and applied pharmacology.
[29] A. Neves,et al. Solid lipid nanoparticles as a vehicle for brain-targeted drug delivery: two new strategies of functionalization with apolipoprotein E , 2015, Nanotechnology.
[30] Abhinav Kumar,et al. Enrichment of immunoregulatory proteins in the biomolecular corona of nanoparticles within human respiratory tract lining fluid. , 2016, Nanomedicine : nanotechnology, biology, and medicine.
[31] Warren C. W. Chan,et al. Understanding and Controlling the Interaction of Nanomaterials with Proteins in a Physiological Environment , 2012 .
[32] Marilena Hadjidemetriou,et al. In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles. , 2015, ACS nano.
[33] J. Kreuter. Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (BBB) , 2013, Journal of microencapsulation.
[34] Jin Won Hyun,et al. Endoplasmic reticulum stress signaling is involved in silver nanoparticles-induced apoptosis. , 2012, The international journal of biochemistry & cell biology.
[35] Jelena Srebric,et al. Advanced computational modeling for in vitro nanomaterial dosimetry , 2015, Particle and Fibre Toxicology.
[36] Frank A. Witzmann,et al. Silver Nanoparticle Protein Corona Composition in Cell Culture Media , 2013, PloS one.
[37] Andrzej S Pitek,et al. Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard corona. , 2012, ACS nano.
[38] Jiwen Zheng,et al. Silver Nanoparticle-Induced Autophagic-Lysosomal Disruption and NLRP3-Inflammasome Activation in HepG2 Cells Is Size-Dependent. , 2016, Toxicological sciences : an official journal of the Society of Toxicology.
[39] S. Homer-Vanniasinkam,et al. Scavenger Receptor Structure and Function in Health and Disease , 2015, Cells.
[40] Iseult Lynch,et al. Designing the nanoparticle-biomolecule interface for "targeting and therapeutic delivery". , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[41] Aristidis Tsatsakis,et al. Protein bio-corona: critical issue in immune nanotoxicology , 2016, Archives of Toxicology.
[42] Kenneth A Dawson,et al. Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency. , 2013, Journal of the American Chemical Society.
[43] Iseult Lynch,et al. Formation and characterization of the nanoparticle-protein corona. , 2013, Methods in molecular biology.
[44] Kenneth A. Dawson,et al. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.
[45] Fengjuan Wang,et al. The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomes. , 2013, Nanomedicine : nanotechnology, biology, and medicine.
[46] Jim E Riviere,et al. Protein binding modulates the cellular uptake of silver nanoparticles into human cells: implications for in vitro to in vivo extrapolations? , 2013, Toxicology letters.
[47] Joel M. Cohen,et al. A critical review of in vitro dosimetry for engineered nanomaterials. , 2015, Nanomedicine.
[48] C. Payne,et al. Impact of Serum Proteins on MRI Contrast Agents: Cellular Binding and T2 relaxation. , 2014, RSC advances.
[49] Murali M. Yallapu,et al. Implications of protein corona on physico-chemical and biological properties of magnetic nanoparticles. , 2015, Biomaterials.
[50] Stefan Tenzer,et al. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. , 2011, ACS nano.
[51] Diego Stéfani T. Martinez,et al. Silver nanoparticle protein corona and toxicity: a mini-review , 2015, Journal of Nanobiotechnology.
[52] Philip M. Kelly,et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. , 2013, Nature nanotechnology.
[53] Ran Chen,et al. Comparison of nanotube-protein corona composition in cell culture media. , 2013, Small.
[54] Sung Tae Kim,et al. Regulation of Macrophage Recognition through the Interplay of Nanoparticle Surface Functionality and Protein Corona. , 2016, ACS nano.
[55] M. Engelhard,et al. Comparison of 20 nm silver nanoparticles synthesized with and without a gold core: Structure, dissolution in cell culture media, and biological impact on macrophages. , 2015, Biointerphases.